July 23 (Reuters) - Milestone Pharmaceuticals Inc MIST.O :
* MILESTONE PHARMACEUTICALS ANNOUNCES REGULATORY GUIDANCE AND UPDATED CLINICAL DEVELOPMENT PLAN FOR ETRIPAMIL IN PSVT
* MILESTONE PHARMA- RECENTLY COMPLETED NODE-301 AND ONGOING NODE-301B STUDIES CAN BE USED AS TWO EFFICACY STUDIES SUPPORTING A FUTURE NDA SUBMISSION
* MILESTONE PHARMACEUTICALS INC - ENTERED INTO A SECURITIES PURCHASE AGREEMENT WITH EXISTING SHAREHOLDER RTW INVESTMENTS